RadNet (RDNT) | Financial Analysis & Statements
RadNet Inc. Mid-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Dec 2025Income Metrics
Revenue
547.7M
Gross Profit
75.9M
13.86%
Operating Income
35.1M
6.40%
Net Income
9.9M
1.80%
Balance Sheet Metrics
Total Assets
3.8B
Total Liabilities
2.4B
Shareholders Equity
1.4B
Debt to Equity
1.77
Cash Flow Metrics
Operating Cash Flow
78.2M
Free Cash Flow
33.1M
Revenue & Profitability Trend
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
RadNet Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.0B | 1.8B | 1.6B | 1.4B | 1.3B |
| Cost of Goods Sold | 1.8B | 1.6B | 1.4B | 1.3B | 1.1B |
| Gross Profit | 235.5M | 249.1M | 221.4M | 165.7M | 191.8M |
| Gross Margin % | 11.5% | 13.6% | 13.7% | 11.6% | 14.6% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | - | - | - |
| Other Operating Expenses | - | - | - | - | -9.1M |
| Total Operating Expenses | 0 | 0 | 0 | 0 | -9.1M |
| Operating Income | 83.4M | 111.3M | 93.0M | 49.8M | 104.2M |
| Operating Margin % | 4.1% | 6.1% | 5.8% | 3.5% | 7.9% |
| Non-Operating Items | |||||
| Interest Income | - | - | - | - | - |
| Interest Expense | 69.9M | 79.8M | 64.5M | 50.8M | 48.8M |
| Other Non-Operating Income | 18.5M | 13.4M | 10.3M | 44.0M | 3.5M |
| Pre-tax Income | 31.9M | 44.9M | 38.8M | 43.0M | 58.9M |
| Income Tax | 14.9M | 6.0M | 8.5M | 9.4M | 14.6M |
| Effective Tax Rate % | 46.6% | 13.4% | 21.8% | 21.8% | 24.7% |
| Net Income | 17.0M | 38.8M | 30.3M | 33.6M | 44.3M |
| Net Margin % | 0.8% | 2.1% | 1.9% | 2.4% | 3.4% |
| Key Metrics | |||||
| EBITDA | 342.3M | 349.1M | 306.9M | 243.1M | 264.7M |
| EPS (Basic) | - | $0.04 | $0.05 | $0.19 | $0.47 |
| EPS (Diluted) | - | $0.04 | $0.05 | $0.17 | $0.46 |
| Basic Shares Outstanding | - | 73037237 | 63580059 | 56293336 | 52496679 |
| Diluted Shares Outstanding | - | 73037237 | 63580059 | 56293336 | 52496679 |
Income Statement Trend
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
RadNet Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 767.2M | 740.0M | 342.6M | 127.8M | 134.6M |
| Short-term Investments | - | - | - | - | - |
| Accounts Receivable | 200.3M | 185.8M | 163.7M | 166.4M | 135.1M |
| Inventory | - | - | - | - | - |
| Other Current Assets | 52.0M | 51.5M | 47.7M | 54.0M | 49.2M |
| Total Current Assets | 1.0B | 1.0B | 579.3M | 367.2M | 324.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.6B | 1.5B | 1.3B | 1.3B | 1.2B |
| Goodwill | 2.0B | 1.5B | 1.4B | 1.5B | 1.1B |
| Intangible Assets | 148.5M | 81.4M | 90.6M | 106.2M | 56.6M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 42.0M | 36.8M | 48.0M | 55.5M | 53.0M |
| Total Non-Current Assets | 2.7B | 2.3B | 2.1B | 2.1B | 1.7B |
| Total Assets | 3.8B | 3.3B | 2.7B | 2.4B | 2.1B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 153.2M | 96.4M | 122.9M | 102.7M | 86.5M |
| Short-term Debt | 87.4M | 81.3M | 74.0M | 70.0M | 76.6M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | - |
| Total Current Liabilities | 586.8M | 479.7M | 437.5M | 466.7M | 374.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 1.8B | 1.6B | 1.4B | 1.4B | 1.3B |
| Deferred Tax Liabilities | 21.9M | 22.2M | 15.8M | 9.3M | 0 |
| Other Non-Current Liabilities | 22.5M | 3.8M | 6.7M | 23.0M | 16.4M |
| Total Non-Current Liabilities | 1.8B | 1.7B | 1.4B | 1.5B | 1.3B |
| Total Liabilities | 2.4B | 2.2B | 1.9B | 1.9B | 1.7B |
| Equity | |||||
| Common Stock | 8.0K | 7.0K | 7.0K | 6.0K | 5.0K |
| Retained Earnings | -95.4M | -76.8M | -79.6M | -82.6M | -93.3M |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.4B | 1.1B | 813.4M | 491.5M | 346.2M |
| Key Metrics | |||||
| Total Debt | 1.9B | 1.7B | 1.5B | 1.5B | 1.4B |
| Working Capital | 445.4M | 539.5M | 141.8M | -99.5M | -50.5M |
Balance Sheet Composition
RadNet Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 17.0M | 38.8M | 30.3M | 33.6M | 44.3M |
| Depreciation & Amortization | 212.0M | 198.4M | 189.5M | 184.7M | 170.7M |
| Stock-Based Compensation | 54.6M | 29.8M | 26.8M | 23.8M | 25.2M |
| Working Capital Changes | -9.8M | -111.4M | -40.3M | -58.7M | -92.1M |
| Operating Cash Flow | 285.6M | 163.3M | 210.6M | 185.8M | 171.0M |
| Investing Activities | |||||
| Capital Expenditures | -212.0M | -187.9M | -187.4M | -245.5M | -214.9M |
| Acquisitions | -137.6M | -45.2M | -14.0M | -1.4M | -1.4M |
| Investment Purchases | - | - | - | - | 0 |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -343.9M | -233.1M | -201.5M | -246.9M | -216.4M |
| Financing Activities | |||||
| Share Repurchases | - | - | - | - | - |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 99.0M | 863.8M | 0 | 148.0M | 717.3M |
| Debt Repayment | -27.8M | -698.4M | -44.0M | -53.8M | -751.1M |
| Financing Cash Flow | 66.8M | 397.3M | 195.5M | 93.4M | -24.1M |
| Free Cash Flow | 85.6M | 45.0M | 33.3M | -103.0M | -71.2M |
| Net Change in Cash | 8.5M | 327.5M | 204.6M | 32.2M | -69.5M |
Cash Flow Trend
RadNet Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
1,425.75
Forward P/E
54.97
Price to Book
4.01
Price to Sales
2.17
PEG Ratio
54.97
Profitability Ratios
Profit Margin
-0.91%
Operating Margin
6.83%
Return on Equity
1.37%
Return on Assets
1.61%
Financial Health
Current Ratio
1.76
Debt to Equity
137.10
Beta
1.53
Per Share Data
EPS (TTM)
$-0.25
Book Value per Share
$14.08
Revenue per Share
$27.13
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| RDNT | 4.5B | 1,425.75 | 4.01 | 1.37% | -0.91% | 137.10 |
| Thermo Fisher | 174.6B | 25.84 | 3.31 | 13.52% | 15.15% | 82.91 |
| Danaher | 126.4B | 34.61 | 2.40 | 7.08% | 14.89% | 37.17 |
| Revvity | 9.7B | 45.77 | 1.46 | 3.22% | 8.45% | 46.87 |
| Icon plc | 9.0B | 15.52 | 0.94 | 6.27% | 7.40% | 38.26 |
| Charles River | 8.3B | 681.33 | 2.61 | -4.23% | -3.60% | 81.95 |
Financial data is updated regularly. All figures are in the company's reporting currency.





